Communities across the country are contending with a steady erosion of a piece of health infrastructure many residents rarely think about until it disappears: the neighborhood pharmacy. A wave of closures affecting both large retail chains and independently owned drugstores has continued this year, deepening what researchers who study healthcare access now commonly refer to as pharmacy deserts, areas where residents must travel a significant distance to fill a prescription, purchase over-the-counter medication, or receive basic pharmacy-administered services like vaccinations.
What's Driving the Closures
The closures stem from overlapping financial pressures that have squeezed pharmacy operations from multiple directions simultaneously. Reimbursement rates that pharmacies receive from insurance plans and the intermediary companies that negotiate drug pricing on behalf of insurers have declined in real terms even as the operational costs of running a pharmacy, staffing, rent, and the cost of the medications themselves, have continued to rise. Independent pharmacy owners describe a business model that, for many common generic medications, now operates at a loss or a razor-thin margin, surviving primarily on the higher-margin front-of-store retail sales that increasingly cannot offset losses on the pharmacy counter itself. Large chains, facing similar reimbursement pressure across thousands of locations, have responded by closing underperforming stores, often concentrated in lower-income neighborhoods and rural areas where prescription volume is lower and real estate costs, while typically cheaper, are outweighed by thinner overall margins.
Communities Hit Hardest
The communities most affected by these closures tend to share certain characteristics that researchers studying healthcare access have documented in prior waves of pharmacy consolidation: they are disproportionately lower-income, disproportionately rural or in urban neighborhoods with limited public transportation, and disproportionately home to older residents and people with chronic conditions who rely on regular, predictable access to medication. When a pharmacy closes in these areas, the nearest alternative is often not simply less convenient but genuinely difficult to reach for residents without reliable personal transportation, and researchers have found that prescription abandonment, patients failing to pick up or refill medications, tends to rise measurably in the aftermath of a closure, even when patients technically retain insurance coverage and the financial ability to pay for their medications.
Policy Responses Under Consideration
The policy responses under consideration in state legislatures this year generally fall into a few categories. Some states are examining reimbursement reform targeted at the intermediary companies that negotiate drug pricing, arguing that greater transparency and stricter regulation of how these companies set reimbursement rates for pharmacies could help address the underlying financial pressure driving closures, particularly for independent pharmacies that lack the negotiating leverage of large chains. Other proposals focus on expanding the scope of services pharmacists are legally permitted to provide, such as administering a broader range of vaccinations, conducting certain point-of-care testing, and prescribing select medications directly, on the theory that expanded scope of practice could help pharmacies diversify revenue and make remaining locations, particularly in underserved areas, more financially sustainable. A smaller number of states have explored direct subsidies or grant programs aimed at supporting pharmacies that serve as the sole provider in a designated pharmacy desert, modeled loosely on existing rural hospital support programs.
Health policy researchers note that pharmacy access has historically received less policy attention than hospital or primary care access, despite pharmacies often serving as one of the most frequent points of contact patients have with the healthcare system, particularly for managing chronic conditions that require ongoing medication. Pharmacists themselves have increasingly been recognized in health services research as an underutilized resource for basic preventive care and medication management, a recognition that has fueled some of the scope-of-practice expansion proposals, even as the financial pressures driving closures continue largely unaddressed by those same proposals.
Rural health advocates describe pharmacy closures as compounding an already difficult access landscape in many of the same communities also experiencing hospital closures and physician shortages, creating what some researchers characterize as a cumulative erosion of healthcare infrastructure that makes each individual closure, evaluated in isolation, appear more manageable than the combined effect across a community that has lost several access points within a short span of years. As state legislative sessions continue to take up reimbursement and scope-of-practice proposals, the underlying financial pressures on pharmacy operations show few signs of easing on their own, leaving open the question of whether policy intervention can outpace the continuing wave of closures or whether pharmacy deserts will simply continue to widen in the meantime.
